{"name":"Lustre Pharmaceutical Lab Co., Ltd","slug":"lustre-pharmaceutical-lab-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Benzalkonium Chloride Solution","genericName":"Benzalkonium Chloride Solution","slug":"benzalkonium-chloride-solution","indication":"Bacterial skin elimination","status":"marketed"}]}],"pipeline":[{"name":"Benzalkonium Chloride Solution","genericName":"Benzalkonium Chloride Solution","slug":"benzalkonium-chloride-solution","phase":"marketed","mechanism":"Small molecule","indications":["Bacterial skin elimination"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPOGcwYTJGckNnQWNaMUlaYmFhSDltMUl6OTBMeWFPT3EwQ2lhQkdTWDgteTdqYUFNVFQ3SnlwNERhM3hWdlZLUG0ya0c1YVpCN3IzR09oRlVXUEZIRWJRMUJZMDhDRGVWWl9QRHRlTE1rOGUxeERpMzg3bmY3WnFsMVVLWGtTMEVhenBSdnRGaXJMcXMtYmNlczBneHB5bnJnWkNDLWRzczBPZzNlR0l6LXpwTVh2clpPUTU2RTNfVnlDM0ZibjZPOThqcU1RbUo3cnBkb0tlRzdpWUpoVWc?oc=5","date":"2025-03-21","type":"pipeline","source":"Reuters","summary":"Gene therapy loses luster as investors eye quicker returns from weight-loss drugs - Reuters","headline":"Gene therapy loses luster as investors eye quicker returns from weight-loss drugs","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}